Mylan's Chairman was Right | Ctech
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters
Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | Reuters
US court invalidates key TEVA drug patent
Fears of Israeli job cuts at Teva sparks call for general strike | Reuters
Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
Teva, Texas strike opioid settlement worth $225 million - The Jerusalem Post
/cloudfront-us-east-2.images.arcpublishing.com/reuters/MH2PVUNNZRPNDLH3JJFMAIF3GE.jpg "Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters")
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
What's 'down' with Teva? - Israel News - The Jerusalem Post
Teva and Eli Lilly scrap over migraine drug rights — MedWatch
Drug-maker Teva fueled opioid addiction in NY, jury finds | Business Insurance
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Teva to proceed with Rimsa breach of contract suit after ruling | Reuters
Teva, Texas strike opioid settlement worth $225M | Business Insurance
Teva's $420mn investor settlement to be mostly covered by insurers | The Insurer
Teva Pharmaceutical | PBS NewsHour
Exclusive: CVS to Cover Migraine Drugs From Teva, Lilly; Excludes Amgen
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PTTVJLJBQNLRBHDEX576PT7LII.jpg "Teva expects to start paying U.S. opioid settlement in 2023 | Reuters")
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO | Reuters
Biden admin urges Supreme Court to hear 'skinny labels' case between Teva, GSK | Reuters
Teva CEO Exits Amid Crisis of Confidence at Drugmaker
Teva hopes Sanofi collaboration will lead to blockbuster IBD drug | Reuters
Teva expects sales injection from U.S. EpiPen market | Reuters
Teva Pharmaceutical Is in Recovery - WSJ
Teva rejects Israeli PM's request to keep Jerusalem plant open | Reuters
